Furthermore, the discovery of tumor-specific CD4+ T cells, which recognize MHC II-restricted tumor antigens such as tyrosinase, CDC27, gp100, MAGE-3, Melan-A/MART-1, Eph receptor, and NY-ESO-1, underscores their importance in tumor immunity14-21. The gene discussed is CD4; the disease is neoplasm.